Article

Genetic variant may have effect on macular degeneration

According to research released in the British Journal of Ophthalmology, genetic variations that affect the production of several chemicals in the inflammation pathways could provide more information about age-related macular degeneration.

Southampton, England-According to research released in the British Journal of Ophthalmology, genetic variations that affect the production of several chemicals in the inflammation pathways could provide more information about age-related macular degeneration (AMD).

Genes controlling the production and suppression of cytokines were investigated by researchers from the University of Southampton. The four specific gene variations each related to control of expression of certain cytokines.

DNA samples from people aged 55 or older were examined and 478 were people presenting with AMD and 555 people showed no signs of the disease. One genetic variant examined (251 A/T) is associated with the gene-boosting production of interleukin 8 (IL-8), which in previous studies was more prevalent in patients with AMD.

A test could be created to help screen for AMD in a larger study, according to the authors. Further studies are necessary before any direct causal relationships can be confirmed, though, according to researchers.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.